MiFID Not an Advantage for U.S. Research, Says Bevan

The video discusses the confusion surrounding research benefits, focusing on the US and EU jurisdictions. It highlights the roles of different players, such as fund managers and broker dealers, and the challenges of unbundling research. The video also addresses the regulatory issues and the impact on competitive advantage. As the deadline approaches, there is chaos in pricing strategies, with a clear trend towards the buy side paying in cash, benefiting customers. However, ambiguity remains in pricing strategies for the sell side.

What is the main point of confusion discussed in the first section regarding research unbundling?

• The advantage of EU players

• Whether it leads to better research

• The role of US fund managers

• The impact on European fund managers

Which entities are involved in the unbundling process according to the first section?

• Only US research and broker dealer providers

• Only European fund managers and US fund managers

• European fund managers, US fund managers, US research and broker dealer providers, and EU players

• Only US fund managers and EU players

What is the EU's stance on European fund managers taking bundled research from the US?

• They prohibit it

• They have no specific stance

• They allow it with restrictions

• They encourage it

What is a significant concern for broker dealers in the US regarding unbundling?

• Lack of demand for research

• Extra cost layer and regulatory burden

• Limited access to European markets

• Increased competition

What trend is highlighted in the final section regarding the buy side?

• They are merging with the sell side

• They are playing hard cash

• They are focusing on European markets

• They are reducing their investments